Clinical Trials Logo

Filter by:
NCT ID: NCT00185393 Completed - Clinical trials for Lymphoma, Non-Hodgkin

Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

Start date: August 2001
Phase: Phase 3
Study type: Interventional

The aim of the study is to test [90]Y-ibritumomab tiuxetan, a radioactive antibody, in patients with stage III or IV follicular lymphoma whose disease is in partial or complete remission after first line chemotherapy. The radioactive antibody will be compared with no further treatment to see which is better in the long term after standard lymphoma treatment.

NCT ID: NCT00185315 Completed - Clinical trials for Hypertension, Pulmonary

Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension

Start date: February 2000
Phase: Phase 3
Study type: Interventional

The aim of this study is to monitor long-term safety and tolerability of iloprost aerosol inhalation therapy in patients suffering from pulmonary hypertension.

NCT ID: NCT00185211 Completed - Multiple Sclerosis Clinical Trials

BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study

Start date: August 2002
Phase: Phase 3
Study type: Interventional

This study will primarily compare the long-term effects of an early and continued treatment with Betaferon/Betaseron (patients who were treated with active medication during the double-blind BENEFIT study) to treatment initiated either after Clinically Definite Multiple Sclerosis (CDMS) has been diagnosed or after two years (those patients who were treated with placebo during the double-blind BENEFIT study). Analyses are based on the integrated data of the initial BENEFIT study and this follow-up study.

NCT ID: NCT00184795 Completed - Menopause Clinical Trials

Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations

CHOICE
Start date: May 28, 2004
Phase: Phase 3
Study type: Interventional

This trial is conducted in Europe. Postmenopausal women with moderate to severe hot flashes have been recruited into the trial. The earliest effect of ultra low dose HRT (hormone replacement therapy) on frequency and severity of menopausal symptoms, bleeding patterns and safety of different hormonal combinations will be evaluated and compared to placebo over the six month treatment period.

NCT ID: NCT00184678 Completed - Clinical trials for Adult Growth Hormone Deficiency

Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

Start date: February 2002
Phase: Phase 3
Study type: Interventional

This trial is conducted in Europe. Growth Hormone in young adults with growth hormone deficiency in childhood. This trial compares a treated group of patients with an untreated group of patients.

NCT ID: NCT00184574 Completed - Clinical trials for Diabetes Mellitus, Type 2

Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

Start date: April 2005
Phase: Phase 3
Study type: Interventional

This trial is conducted in Europe. This trial aims for a comparison of the effect on glycemic control in subjects with type 2 diabetes of three different premixed insulin analogues given in combination with an oral anti-diabetic drug.

NCT ID: NCT00182819 Completed - Clinical trials for Brain and Central Nervous System Tumors

Radiation Therapy or Temozolomide in Treating Patients With Gliomas

Start date: July 2005
Phase: Phase 3
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether radiation therapy is more effective than temozolomide in treating gliomas. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared to temozolomide in treating patients with gliomas.

NCT ID: NCT00180596 Completed - Heart Failure Clinical Trials

PACMAN - PAcing for CardioMyopathies, a EuropeAN Study

Start date: January 2000
Phase: Phase 4
Study type: Interventional

The purpose of this study was to evaluate the benefit of biventricular pacing in patients with heart failure who were receiving optimal pharmacological therapy, and who were either with or without an ICD indication

NCT ID: NCT00180505 Completed - Clinical trials for Peripheral Vascular Diseases

ASSESS Study: Evaluation of ABSOLUTEā„¢ Stent System for Occluded Arteries

Start date: March 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the performance of the ABSOLUTEā„¢ .035 peripheral self-expanding stent system in preventing restenosis of occluded or stenotic superficial femoral or proximal popliteal arteries.

NCT ID: NCT00180466 Completed - Clinical trials for Coronary Artery Disease

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Start date: October 2004
Phase: N/A
Study type: Observational

PROSPECT is a multi-center prospective registry of Acute Coronary Syndromes (ACS) patients with single or double vessel coronary artery disease. Approximately 700 patients with ACS will be enrolled into the study at sites in the United States and European Union.